Atezolizumab addition to platinum doublet: evaluating survival outcomes for patients with extensive disease small cell lung cancer.

Sousuke Kubo,Nobuaki Kobayashi,Hiromi Matsumoto,Kohei Somekawa,Ayami Kaneko,Hisashi Hashimoto,Shuhei Teranishi,Keisuke Watanabe,Nobuyuki Horita,Yu Hara,Makoto Kudo,Takeshi Kaneko

Journal of cancer research and clinical oncology（2023）

引用 0|浏览6

暂无评分

摘要

The addition of atezolizumab to the platinum doublet regimen significantly extended OS in ED-SCLC patients, particularly among certain subgroups, suggesting its potential value in personalized treatment strategies. Further investigation is warranted to validate these findings.

查看译文

关键词

small cell lung cancer,lung cancer,atezolizumab addition,platinum doublet

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要